JIN MEDICAL INTERNATIONAL may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, JIN MEDICAL's Cash And Short Term Investments are quite stable compared to the past year. Common Stock Shares Outstanding is expected to rise to about 188.9 M this year, although the value of Other Current Liabilities will most likely fall to about 592.7 K. Key indicators impacting JIN MEDICAL's financial strength include:
Investors should never underestimate JIN MEDICAL's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor JIN MEDICAL's cash flow, debt, and profitability to make informed and accurate decisions about investing in JIN MEDICAL INTERNATIONAL.
Net Income
3.25 Million
JIN
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Average Inventory
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Investments
Change In Cash
Net Borrowings
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Total Cashflows From Investing Activities
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Change To Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Issuance Of Capital Stock
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Net Tangible Assets
Property Plant And Equipment Net
Current Deferred Revenue
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Cash And Short Term Investments
Net Receivables
Common Stock Shares Outstanding
Short Term Investments
Liabilities And Stockholders Equity
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Total Current Assets
Accumulated Other Comprehensive Income
Short Term Debt
Intangible Assets
Common Stock
Property Plant Equipment
Net Invested Capital
Property Plant And Equipment Gross
Short Long Term Debt
Capital Stock
Net Working Capital
Depreciation And Amortization
Interest Expense
Selling General Administrative
Selling And Marketing Expenses
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income Applicable To Common Shares
Income Tax Expense
Tax Provision
Net Interest Income
Net Income From Continuing Ops
Reconciled Depreciation
Interest Income
Probability Of Bankruptcy
Understanding current and past JIN MEDICAL Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of JIN MEDICAL's financial statements are interrelated, with each one affecting the others. For example, an increase in JIN MEDICAL's assets may result in an increase in income on the income statement.
Comparative valuation techniques use various fundamental indicators to help in determining JIN MEDICAL's current stock value. Our valuation model uses many indicators to compare JIN MEDICAL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across JIN MEDICAL competition to find correlations between indicators driving JIN MEDICAL's intrinsic value. More Info.
JIN MEDICAL INTERNATIONAL is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for JIN MEDICAL INTERNATIONAL is roughly 2.25 . At this time, JIN MEDICAL's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value JIN MEDICAL by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
JIN MEDICAL INTERNATIONAL Systematic Risk
JIN MEDICAL's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. JIN MEDICAL volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on JIN MEDICAL INTERNATIONAL correlated with the market. If Beta is less than 0 JIN MEDICAL generally moves in the opposite direction as compared to the market. If JIN MEDICAL Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one JIN MEDICAL INTERNATIONAL is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of JIN MEDICAL is generally in the same direction as the market. If Beta > 1 JIN MEDICAL moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in JIN MEDICAL Stock are looking for potential investment opportunities by analyzing not only static indicators but also various JIN MEDICAL's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of JIN MEDICAL growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of JIN MEDICAL help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of JIN MEDICAL INTERNATIONAL. We use our internally-developed statistical techniques to arrive at the intrinsic value of JIN MEDICAL INTERNATIONAL based on widely used predictive technical indicators. In general, we focus on analyzing JIN Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build JIN MEDICAL's daily price indicators and compare them against related drivers.
When determining whether JIN MEDICAL INTERNATIONAL is a strong investment it is important to analyze JIN MEDICAL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact JIN MEDICAL's future performance. For an informed investment choice regarding JIN Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.676
Earnings Share
0.02
Revenue Per Share
0.15
Quarterly Revenue Growth
0.353
Return On Assets
0.0578
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.